Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Orchard Therapeutics (ORTX) - Net assets
Net assets on the balance sheet as of September 2023 : $80.25 M
According to Orchard Therapeutics
's latest financial reports the company has $80.25 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Orchard Therapeutics - Net assets on balance sheet (from 2017 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $98.26 M | -53.2% |
| 2021-12-31 | $0.20 B | 17.66% |
| 2020-12-31 | $0.17 B | -40.36% |
| 2019-12-31 | $0.29 B | -3.9% |
| 2018-12-31 | $0.31 B | 260.32% |
| 2017-12-31 | $86.4 M | -622.91% |
| 2016-12-31 | $-16.53 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $6.18 M | -92.30% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | 0.00% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | -993.28% | 🇺🇸 USA |
 Novocure
NVCR | $0.36 B | 351.66% | Jersey |